Orexo
Search
Related links
Orexo (svensk)
Orexo (English)
Kibion (svensk)
Kibion (English)
Home
About Orexo
Products
Portfolio
Partners
Investors
Press
Contact
Start
/
Press
/
Press releases
Press releases
2010
/
2009
/
2008
/
2007
2007-12-17
Orexo´s partner Endo announces positive results from interim analysis of Rapinyl ™ phase III clinical trial
2007-11-30
Changed number of shares and votes in Orexo AB
2007-11-26
Orexo announces new Executive Management Team
2007-11-23
Orexo completes the acquisition of Biolipox, appoints new CEO and publishes a prospectus
2007-11-21
The board of directors of Orexo resolves to issue new shares with payment in kind
2007-11-20
Biolipox completes aquisition from Inflazyme
2007-11-13
Report from Orexo AB’s Extraordinary Shareholders’ Meeting
2007-11-12
Orexo acquires Biolipox – Update regarding revised transaction structure and proposal regarding election of chairman and members of the board of directors for the Extraordinary General Meeting on November 13, 2007
2007-11-05
Nomination Committee for Orexo’s Annual General Meeting 2008
2007-11-01
Endo announces update on Phase III-program for Orexo´s pain product Rapinyl™
2007-10-30
Notice of Extraordinary Shareholders’ Meeting in Orexo AB
2007-10-26
Orexo to acquire Biolipox - Update
2007-10-25
Orexo signs distribution agreement with Hospira in Asia for pain product Rapinyl™
2007-10-23
Interim Report January - September 2007
2007-10-18
Changed date for the Q3 2007 report
2007-10-16
Notice of Extraordinary Shareholders’ Meeting in Orexo AB
2007-10-15
Orexo to acquire Biolipox - building a specialty pharma company driven by innovation
2007-10-03
Orexo adds two new projects to its development pipeline - abuse proof opioid and a new quick acting treatment for moderate to severe acute pain
2007-10-01
Orexo shows positive results in completed comparative Phase III profile study of the Sublinox™ sleep aid involving insomnia patients
2007-09-28
Orexo’s Rapinyl™ nearing regulatory decision in Europe
2007-08-29
Orexo´s treatment for incontinence/nocturia entering Phase I
2007-08-17
Orexo strengthens its clinical and regulatory team with the appointment of three senior executives
2007-08-14
Interim Report January - June 2007
2007-08-01
Orexo establishes sales force in Nordic markets, by entering into a joint venture with ProStrakan
2007-05-09
Interim Report, January - March 2007
2007-05-09
Orexo receives European patent approval for OX 17
2007-04-24
Report from Orexo AB’s Annual General Meeting, 23 April 2007
Press releases
Subscribe
News
Publications
Image archive